Research Use Only
5-Amino-1MQ Capsules
$209.00
Quantity: 60 Capsules
In stock
| # Purchased | Discounted Price |
|---|---|
| 5 - 9 | $198.55 |
| 10 + | $188.10 |
- Product Reference
- 5AM-CAP-50MG
- Documentation
- Find This Product’s Reports ↗
For laboratory research use only. Not for human consumption. No dosing or administration guidance is provided.
About 5-Amino-1MQ Capsules
Material5-Amino-1MQ Capsules
Available OptionsQuantity: 60 Capsules
5-Amino-1MQ Capsules contain 5-amino-1-methylquinolinium, a small molecule with the formula C10H11N2+ and purity above 98.5%. Moreover, it comes in capsule form, allowing consistent portioning and easy handling in laboratory research. Each batch goes through strict quality checks to ensure purity, stability, and consistency.
The enzyme NNMT normally changes nicotinamide, a form of vitamin B3, by using methyl groups, which lowers nicotinamide adenine dinucleotide (NAD+) levels.
Many labs now focus on NAD+ biology.
In addition, researchers study the compound in laboratory settings. 5-Amino-1MQ Capsules remain important in labs exploring metabolism and cell biology.
Researchers must use 5-Amino-1MQ Capsules only in laboratory and early-stage studies. They do not suit human use, and trained staff follow strict laboratory safety rules at all times. Therefore, proper safety practices remain essential.
Product. Strength. Lot.
Search the original archive for 5-Amino-1MQ Capsules. Verify the complete lot number on your label against the report.
Supporting Images 1 files
Original images attached to this product. For lot, strength and report dates, use the searchable archive above and verify the document itself.
- Catalog Name
- 5-Amino-1MQ Capsules
- Product Reference
- 5AM-CAP-50MG
- Intended Use
- Laboratory research only
| Quantity | 60 Capsules |
|---|
Shipping and returns
Need a product or lot record?
Include the product name and lot number when contacting support.
Contact support
Watowich, P.A., et al. (2022). "Nicotinamide N-methyltransferase inhibition for treatment of age-associated functional decline in mice."
Kraus, D., et al. (2014). "Nicotinamide N-methyltransferase an emerging player in metabolic diseases."
